Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and[...]
Materion Corporation Reports Third Quarter 2024 Financial Results Form 8 K
08/01/2024 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Biogen Inc. | News | Health | Finance | Security Markets | Security Markets | Company News | Corporate Debt | Securities Issuers | Pharmaceutical Companies | Borsa Italiana | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Santiago Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | Kazakhstan Stock Exchange (KASE) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Bolsa Electrónica de Chile | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | EuroTLX | Bolsa Institucional de Valores (BIVA) | Hannover Stock Exchange | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact